12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Genisphere, Lankenau Institute deal

Genisphere and the not-for-profit institute added the development of biomarkers for Crohn's disease and other inflammatory bowel disorders to a deal to develop microRNA biomarkers for ulcerative colitis (UC). Under...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >